- Home
- LDWY vs SYRS Comparison
LDWY vs SYRS Comparison
Compare LDWY & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- SYRS
- Stock Information
- Founded
- LDWY 1990
- SYRS 2011
- Country
- LDWY United States
- SYRS United States
- Employees
- LDWY N/A
- SYRS N/A
- Industry
- LDWY Advertising
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- SYRS Health Care
- Exchange
- LDWY Nasdaq
- SYRS Nasdaq
- Market Cap
- LDWY 8.2M
- SYRS 7.1M
- IPO Year
- LDWY 1991
- SYRS 2016
- Fundamental
- Price
- LDWY $4.60
- SYRS $0.22
- Analyst Decision
- LDWY
- SYRS Hold
- Analyst Count
- LDWY 0
- SYRS 5
- Target Price
- LDWY N/A
- SYRS $3.00
- AVG Volume (30 Days)
- LDWY 6.1K
- SYRS 3.2M
- Earning Date
- LDWY 11-19-2024
- SYRS 10-31-2024
- Dividend Yield
- LDWY N/A
- SYRS N/A
- EPS Growth
- LDWY N/A
- SYRS N/A
- EPS
- LDWY N/A
- SYRS N/A
- Revenue
- LDWY $31,581,000.00
- SYRS $386,000.00
- Revenue This Year
- LDWY N/A
- SYRS N/A
- Revenue Next Year
- LDWY N/A
- SYRS N/A
- P/E Ratio
- LDWY N/A
- SYRS N/A
- Revenue Growth
- LDWY N/A
- SYRS N/A
- 52 Week Low
- LDWY $3.02
- SYRS $0.18
- 52 Week High
- LDWY $6.88
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- LDWY 51.07
- SYRS 37.85
- Support Level
- LDWY $4.38
- SYRS $0.20
- Resistance Level
- LDWY $5.03
- SYRS $0.25
- Average True Range (ATR)
- LDWY 0.19
- SYRS 0.04
- MACD
- LDWY -0.04
- SYRS 0.03
- Stochastic Oscillator
- LDWY 26.19
- SYRS 21.90
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.